Quick Links
Topics
-
Recent Posts
Recent Comments
Terry McCormick on “The Best Drug Companies Of The Past 15 Years?”
Mike - I agree with you that the popular press usually misses your point on...Posted Feb 20, 2012Terry McCormick on Examining the “other end” of the Semantics telescope
A recent article in the Wall Street Journal (see link), gives another example of the...Posted Feb 07, 2012Terry McCormick on Automating Serendipity
Watson has a paying client. One of the more exciting directions for healthcare and...Posted Sep 12, 2011
Blogroll
Links
Category Archives: Uncategorized
“The Truly Staggering Cost Of Inventing New Drugs”
Another provocative piece in Forbes that implies the cost of developing a new drug could be as high as $12B!! This approach has a number of flaws (as does: “Best Drug Companies.. “) All produce (provoke?) some interesting insights from commenters. Funny how … Continue reading
In-progress: NME’s .vs mergers
Note: The following focuses on New Medical Entities (NME’s.) These are defined as the novel, initial member of a chemical family for a drug. The data is derived from the public FDA database on approved drugs for past years. From … Continue reading
Continued laments on R&D performance
Poor performance of Pharma R&D seems to have never left the newsservices or the hearts of all in the industry. It is interesting to see the stories of 2011 echoing back for a decade. Here are some current “news” items … Continue reading
Corante’s “Big Pharma’s Lost Stock Market Decade”
Take a look at the posting and discussions on Derek Lowe’s excellent blog: http://pipeline.corante.com/archives/2010/12/13/big_pharmas_lost_stock_market_decade.php#comments Another version of his chart is here, showing the last two years .vs. Lowe’s decade view. It reveals the same result: the industry has underperformed the … Continue reading